Although STAT1 has traditionally been considered a classic tumor suppressor, an increasing number of studies have shown that STAT1 has a pro-tumor effect in certain tumor contexts, including colorectal, ovarian, and pancreatic cancers (72–75). Here, STAT1 is linked to pancreatic neoplasm.